Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study

Redouane Amine Cherif; Lyèce Yargui; Malika Nawel Bouaicha; Hanane Boukrous; Mahdia Saidi; Yamina Ouarhlent

doi:10.5455/njppp.2019.9.0828210092019

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 18 Sep 2019

Natl J Physiol Pharm Pharmacol. 2019; 9(11): 1134-1138

doi: 10.5455/njppp.2019.9.0828210092019

Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study

Redouane Amine Cherif, Lyèce Yargui, Malika Nawel Bouaicha, Hanane Boukrous, Mahdia Saidi, Yamina Ouarhlent.

Cited By:1

Abstract
Background: Due to the lack of methotrexate (MTX) therapeutic monitoring in some hospitals, clinicians often resort to fixed and higher leucovorin (LCV) doses after intermediate-dose MTX (IDMTX) infusion to prevent toxicities occurrence. A decision that can lead to the inhibition of MTX action or even helps cancer cells to regenerate.

Aims and Objectives: In view of the risks incurred by patients, a study was carried out to determine whether an early and excessive LCV rescue really avoids the occurrence of toxicities after IDMTX infusion and if not, identify the main encountered adverse effects by a clinical and biological monitoring.

Materials and Methods: A cross-sectional study was conducted from November 2014 to February 2016 with a monitoring of clinical data, methotrexatemias, concentrations of biochemical parameters, and a complete blood count. Analyses were performed before the start of the infusion and 24, 48, and 72 h after.

Results: A total of 15 patients were recruited for a total of 23 infusions of MTX at 3 g/m² over 4 h followed by an early and excessive LCV rescue, starting at the 6th h with a cumulative dose of 320 mg/m². Concentrations of MTX lower than 0.05 μmol/L were observed after 72 h in 19 infusions and after 48 h in 11. Six patients experienced toxicities with significantly higher MTX concentrations compared to patients who had no adverse effects.

Conclusion: Despite the early and excessive LCV rescue used during the study, toxicities sometimes fatal, still took place. It is therefore recommended a methotrexatemia monitoring for at least 72 h and an evaluation of the creatinine clearance with neutrophils and lymphocytes numeration whatever the modalities of the rescue.

Key words: Intermediate-dose Methotrexate; Leucovorin; Therapeutic Drug Monitoring

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Redouane Amine Cherif Articles by Lyèce Yargui Articles by Malika Nawel Bouaicha Articles by Hanane Boukrous Articles by Mahdia Saidi Articles by Yamina Ouarhlent
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Cherif RA, Yargui L, Bouaicha MN, Boukrous H, Saidi M, Ouarhlent Y. Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2019; 9(11): 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

Web Style

Cherif RA, Yargui L, Bouaicha MN, Boukrous H, Saidi M, Ouarhlent Y. Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. https://www.njppp.com/?mno=59844 [Access: June 26, 2026].

doi:10.5455/njppp.2019.9.0828210092019

AMA (American Medical Association) Style

Cherif RA, Yargui L, Bouaicha MN, Boukrous H, Saidi M, Ouarhlent Y. Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2019; 9(11): 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

Vancouver/ICMJE Style

Cherif RA, Yargui L, Bouaicha MN, Boukrous H, Saidi M, Ouarhlent Y. Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. Natl J Physiol Pharm Pharmacol. (2019), [cited June 26, 2026]; 9(11): 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

Harvard Style

Cherif, R. A., Yargui, . L., Bouaicha, . M. N., Boukrous, . H., Saidi, . M. & Ouarhlent, . Y. (2019) Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. Natl J Physiol Pharm Pharmacol, 9 (11), 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

Turabian Style

Cherif, Redouane Amine, Lyèce Yargui, Malika Nawel Bouaicha, Hanane Boukrous, Mahdia Saidi, and Yamina Ouarhlent. 2019. Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study. National Journal of Physiology, Pharmacy and Pharmacology, 9 (11), 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

Chicago Style

Cherif, Redouane Amine, Lyèce Yargui, Malika Nawel Bouaicha, Hanane Boukrous, Mahdia Saidi, and Yamina Ouarhlent. "Early and excessive leucovorin rescue in the prevention of toxicities after intermediate-dose methotrexate: A cross-sectional study." National Journal of Physiology, Pharmacy and Pharmacology 9 (2019), 1134-1138.

doi:10.5455/njppp.2019.9.0828210092019

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2019.9.0828210092019

APA (American Psychological Association) Style

doi:10.5455/njppp.2019.9.0828210092019

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article